CoChat

Valproic acid inhibits the protective effects of stromal cells against chemotherapy in breast cancer: Insights from proteomics and systems biology

Barneh, Farnaz, Salimi, Mona, Goshadrou, Fatemeh, Ashtiani, Minoo, Mirzaie, Mehdi, Zali, Hakimeh, Jafari, Mohieddin · 2018 · Journal of Cellular Biochemistry
Cited by 14

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Interaction between tumor and stromal cells is beginning to be decoded as a contributor to chemotherapy resistance. Here, we aim to take a system‐level approach to explore a mechanism by which stromal cells induce chemoresistance in cancer cells and subsequently identify a drug that can inhibit such interaction. Using a proteomic dataset containing quantitative data on secretome of stromal cells, we performed multivariate analyses and found that bone‐marrow mesenchymal stem cells (BM‐MSCs) play the most protective role against chemotherapeutics. Pathway enrichment tests showed that secreted cytokines from BM‐MSCs activated 4 signaling pathways including Janus kinase‐signal transducer and activator of transcription, phosphatidylinositol 3‐kinase‐protein kinase B, and mitogen‐activated protein kinase, transforming growth factor‐β in cancer cells collectively leading to nuclear factor kappa‐light‐chain‐enhancer of activated B cells (NF‐kB) transcription factor activation. Based on the data from integrated Library of Integrated Network‐Based Cellular Signatures (iLINCs) program, we found that among different drugs, valproic acid (VA) affected the expression of 34 genes within the identified pathways that are activated by stromal cells. Our in vitro experiments confirmed that VA inhibits NF‐kB activation in cancer cells. In addition, analyzing gene expression data in patients taking oral VA showed that this drug decreased expression of antioxidant enzymes culminating in increased oxidative stress in tumor cells. These results suggest that VA confines the protective role of stromal cells by inhibiting the adaptation mechanisms toward oxidative stress which is potentiated by stromal cells. Since VA is an already prescribed drug manifesting anticancer effects, this study provides a mechanistic insight for combination of VA with chemotherapy in the clinical setting.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/jcb.27196

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 64

  1. Wang S, 2009, Response to neoadjuvant therapy and disease free survival in patients with triple‐negative breast cancer, Gan to Kagaku Ryoho. Cancer Chemother, 36, 255
  2. 10.1016/j.bbacli.2015.03.003 · DOI · Paper page
  3. 10.1186/bcr3658 · DOI · Paper page
  4. 10.1016/j.bbalip.2015.07.005 · DOI
  5. 10.1016/j.ccr.2005.05.024 · DOI · Paper page
  6. 10.1021/pr700745n · DOI
  7. 10.1038/nm.1908 · DOI · Paper page
  8. 10.1038/nature12626 · DOI · Paper page
  9. 10.1007/s10549-012-2196-0 · DOI
  10. 10.18632/oncotarget.3099 · DOI · Paper page
  11. 10.1159/000366118 · DOI
  12. 10.1038/srep30133 · doi:10.1038/srep30133
  13. 10.1002/jcb.26183 · DOI
  14. 10.1038/nature11183 · DOI · Paper page
  15. Brock G, 2011, clValid, an R package for cluster validation, Journal of Statistical Software
  16. 10.1016/j.bbapap.2013.02.003 · doi:10.1016/j.bbapap.2013.02.003
  17. 10.1093/nar/gkw377 · DOI · Paper page
  18. Barneh F, 2015, Updates on drug‐target network; facilitating polypharmacology and data integration by growth of DrugBank database, Brief Bioinform, 17, 1070
  19. 10.1093/nar/gkx1037 · DOI · Paper page
  20. 10.4103/2277-9175.148291 · DOI
  21. 10.1081/CLT-120014645 · DOI · Paper page
  22. 10.4103/0973-1482.147254 · doi:10.4103/0973-1482.147254
  23. 10.1200/PO.16.00011 · DOI
  24. 10.1093/bioinformatics/btg405 · DOI · Paper page
  25. 10.1007/0-387-29362-0_23 · DOI · Paper page
  26. Wickham H, 2010, ggplot2: elegant graphics for data analysis, J Stat Softw, 35, 65
  27. 10.1155/2013/857895 · doi:10.1155/2013/857895
  28. 10.1016/j.celrep.2017.02.006 · DOI · Paper page
  29. 10.1093/jnci/djm135 · DOI · Paper page
  30. 10.3390/ijms13089545 · DOI · Paper page
  31. 10.1016/j.tcb.2014.11.006 · DOI · Paper page
  32. 10.1016/j.canlet.2015.07.044 · DOI · Paper page
  33. 10.3892/or.2015.4047 · DOI
  34. 10.1038/cr.2010.178 · DOI · Paper page
  35. 10.1021/acs.jmedchem.6b01243 · DOI · Paper page
  36. 10.18632/oncotarget.1658 · DOI
  37. 10.1038/s41467-017-02746-z · DOI · Paper page
  38. 10.1038/nrc3599 · DOI · Paper page
  39. 10.1038/bjc.2012.201 · DOI · Paper page
  40. 10.1016/j.canlet.2007.10.006 · DOI
  41. 10.3325/cmj.2017.58.349 · DOI
  42. 10.1080/15548627.2015.1082024 · DOI · Paper page
  43. 10.3892/ol.2016.4880 · DOI
  44. 10.1155/2010/479364 · DOI · Paper page
  45. Kostrouchová M, 2007, Valproic acid, a molecular lead to multiple regulatory pathways, Folia Biol, 53, 37, 10.14712/fb2007053020037 · DOI
  46. 10.1039/C5TX00476D · DOI
  47. 10.1002/pros.20587 · DOI
  48. 10.1016/j.biocel.2008.08.019 · DOI
  49. 10.1016/j.mce.2009.09.011 · DOI
  50. 10.3892/ijo.2015.3213 · DOI
  51. 10.1517/13543784.2013.853037 · DOI
  52. 10.1186/1756-8722-3-5 · DOI · Paper page
  53. 10.1586/14737140.2014.940329 · DOI
  54. 10.1158/1055-9965.EPI-08-0646 · DOI
  55. 10.1677/joe.1.06970 · DOI · Paper page
  56. 10.1158/0008-5472.CAN-13-1117 · DOI
  57. 10.3390/antiox7010016 · DOI
  58. 10.1155/2012/762825 · DOI · Paper page
  59. 10.4236/mc.2012.11001 · doi:10.4236/mc.2012.11001
  60. 10.1155/2016/4502846 · DOI · Paper page
  61. 10.1158/0008-5472.CAN-06-0814 · DOI
  62. 10.1124/mol.111.072314 · DOI · Paper page
  63. 10.1093/neuonc/nop005 · DOI · Paper page
  64. Barneh F, 2017, A rational drug combination design to inhibit epithelial‐mesenchymal transition in a three‐dimensional microenvironment, bioRxiv, 148767

Cited by

See all 14

Metadata

Authors
Barneh, F., Salimi, M., Goshadrou, F., Ashtiani, M., Mirzaie, M., Zali, H., & Jafari, M.
Affiliations
  • Department of Basic Sciences Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences Tehran Iran
  • Physiology and Pharmacology Department Pasteur Institute of Iran Tehran Iran
  • Drug Design and Bioinformatics Unit, Medical Biotechnology Department Biotechnology Research Center, Pasteur Institute of Iran Tehran Iran
  • Department of Applied Mathematics Faculty of Mathematical Sciences, Tarbiat Modares University Tehran Iran
  • School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical sciences Tehran Iran
Venue
Journal of Cellular Biochemistry
Publisher
Wiley
Published
2018-06-28
Volume
119
Issue
11
Pages
9270-9283
ISSN
  • 0730-2312
  • 1097-4644
Cited by
14
References
2
Language
en
Funders
Cancer Research Network of Iran

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.